Jamaica vs Latvia: Estimated antiretroviral therapy coverage among people living with HIV
Jamaica
52.0%
in 2025
Latvia
52.0%
in 2024
Jamaica rank
122nd
Latvia rank
122nd
Estimated antiretroviral therapy coverage among people living with HIV over time
- Jamaica
- Latvia
How they compare
Jamaica currently reports 52.0% against 52.0% in Latvia, a difference of 0.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Latvia ahead.
Jamaica ranks 122nd and Latvia ranks 122nd of 143 countries.
Jamaica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jamaica | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.4% | 3.1% | 2.3% | Jamaica |
| 2010s | 33.8% | 22.0% | 11.8% | Jamaica |
| 2020s | 50.6% | 49.8% | 0.8% | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Jamaica or Latvia?
- Jamaica, at 52.0% against 52.0% in Latvia as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Jamaica and Latvia?
- 0.0%, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and Latvia?
- 25 years are reported by both, from 2000 to 2024.
- How do Jamaica and Latvia rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Jamaica ranks 122nd and Latvia ranks 122nd of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.